The cannabinoid receptor 2 (CB2) plays a pleiotropic role in innate immunity and is a crucial mediator of liver disease. In the present study, we investigated the impact of CB2 receptors on the regenerative process associated with liver injury. 
INTRODUCTION
The endocannabinoid system comprises two G-protein coupled receptors, CB1 and CB2, a family of lipidic ligands, known as endocannabinoids and a machinery dedicated to endocannabinoid degradation ( , ). CB1 receptors are highly expressed in the central 1 2 nervous system and in a variety of peripheral tissues; in contrast, CB2 receptors show a more restricted distribution, predominating in immune cells ( ). Several recent data suggest that the non-psychoactive cannabinoid receptor CB2 is up-regulated in inflammatory 2 disorders and may represent a critical target for regulation of inflammation, with either pro-or anti-inflammatory properties according to pathophysiological settings. Thus, we have shown that CB2 receptors promote adipose tissue inflammation associated with obesity ( ). In 3 contrast, anti-inflammatory properties of CB2 receptors have been established in experimental models of multiple sclerosis, atherosclerosis, inflammatory bowel disease or liver ischemia reperfusion injury ( ). CB2 receptors have also been identified in 4 -6 non-immune cells, such as osteoblasts, myocytes and cardiac fibroblasts, leading to the characterization of non immune beneficial effects of CB2 agonists on osteoporosis or post-ischemic heart failure ( , ). 1 3 9 ). We have shown that CB1 receptors promote the progression of liver fibrogenesis and that CB1 antagonism is an efficient antifibrotic strategy ( , ) . Moreover, CB1 receptors have also been implicated in the pathogenesis of alcoholic and non alcoholic fatty liver 10 11 disease ( ). Finally, CB1 receptors promote the development of portal hypertension and ascites in cirrhotic animals ( , ). 12 -14 15 16 Unfortunately, exciting potential therapeutic openings derived from these findings have been put to a hold with the withdrawal of the CB1 receptor antagonist rimonabant, due to central adverse effects. Nonetheless, mounting evidences identify CB2 receptors as an alternative target for the management of liver diseases. Thus, we have shown that endogenous activation of CB2 receptors in hepatic myofibroblasts reduces the progression of experimental fibrosis ( ) and a subsequent study established the curative properties of a CB2 agonist in 17 cirrhotic rats ( ). Recent data also indicate that CB2 receptors decrease the extent of liver injury in models of acute insult, as induced by 18
ischemia-reperfusion or concanavalin-A administration ( , ). However, their impact on the regenerative process associated with liver 6 19 injury has not been investigated, as yet. In the present study we show that CB2 receptors reduce liver injury and accelerate liver regeneration via distinct pathways.
METHODS Materials
CCl , mineral oil (MO) and SIN-1 were from Sigma (France), IL-6 from Peprotech (France), JWH-133 from Tocris (ThermoFisher,   4 France), CTTHWGFTLC from Merck (UK).
Animals and experimental design

Animals
Mice invalidated for CB2 receptor (CB2 ) were generated as in ( ) and wild type (WT) C57BL/6J mice were obtained from
Janvier (France). Animals were housed in temperature and humidity controlled rooms, kept on a 12-h light/dark cycle and provided unrestricted amounts of food and water. Male mice aged 8 12 weeks were used. Animal procedures were conducted in accordance with -French government policies (Services V t rinaires de la Sant et de la Production Animale, Minist re de l Agriculture).
CCl -induced liver injury 4 Acute liver injury was induced by a single intraperitoneal (ip) injection of CCl (0.5 ml/kg body weight, 1:5 dilution in MO), as in ( 4 21 ). Control animals received MO. When indicated, mice were treated either with respective vehicle, IL-6 (0.5 mg/kg, subcutaneous), the CB2 agonist JWH-133 (3 mg/kg, ip), the NO donor SIN-1 (10 mg/kg, ip), or the MMP-2/MMP-9 inhibitor CTTHWGFTLC (13 mg/kg, ip), administered before CCl administration. No mortality was observed throughout treatments. Liver samples were taken from several 4 lobes and either fixed in buffered formalin or snap frozen in liquid nitrogen and stored at 80 C until use. Experiments were performed on −°4
9 animals/group.
-
Partial hepatectomy
Two-third hepatectomy was performed as previously described ( ), while animals were under isoflurane anesthesia. After ventral 22 laparotomy, the left lateral, left median and right median lobes were ligated, and excised. The removed liver specimens were weighed and snap frozen in liquid nitrogen to serve as control.
Liver function tests
Alanine aminotransferase activity was measured on an automated analyzer in the Biochemistry Department of Mondor Hospital.
Results are the mean from 15 animals/group.
Liver cell fractionation
Liver cells were digested by two-step collagenase perfusion. Cell suspension was centrifugated at 500 rpm for 2 min. The pellet contained hepatocytes and non-parenchymal cells were purified from the supernatant by density gradient centrifugation with 25 50
Percoll.
TUNEL assay
TUNEL staining was performed on paraffin-embedded tissue sections, using the Cell Death Detection Kit, POD (Roche). In Situ TUNEL-positive area from 2 3 fields (X100)/animal were quantified with Image J. Results are expressed as of total area, and were -% quantified from 7 8 animals/group.
Immunohistochemistry 3 15 Immunohistochemistry was carried out on paraffin-embedded liver tissue sections as previously described ( ). Immunohistochemical 10 detection of PCNA was performed using the MOM immunodetection kit (Vector) and a mouse monoclonal anti-PCNA 
Western blot analysis
Western blot analysis was performed as previously described ( ). Primary antibodies were mouse monoclonal anti-PCNA (1:1,000) 10 or anti-cyclin D1 (1:500) and secondary antibody was peroxidase-conjugated goat anti-mouse IgG antibody (1:5,000), all from Santa Cruz.
Proteins were visualized by an enhanced chemiluminescence assay kit (ECL Plus, GE Healthcare). Signals were quantified using ImageJ.
Quantification relative to -actin (mouse monoclonal 1:100,000, Sigma) was performed on 8 10 animals/group.
β -
RNA preparation and RT-PCR
Total RNA was extracted using RNeasy Mini kit (Qiagen). Real-time PCR was carried out on a LightCycler (Roche), using Quantitech SYBR Green PCR kit (Qiagen), with oligonucleotide primers from MWG Biotech (see ) The PCR amplified products supplementary data were analyzed on a 2 agarose gel, and sequenced. Data are from 6 10 animals/group, % -
Cell culture
Hepatic myofibroblasts
Hepatic myofibroblasts were obtained by outgrowth of explants prepared from surgical specimens of human normal liver, as previously described ( ). This procedure was performed in accordance with ethical regulations imposed by the French legislation. 23
Experiments were performed on confluent cells that were made quiescent by a 48 h incubation in serum-free medium.
Bone-marrow derived macrophages (BMDM)
BMDM were isolated from bone marrow obtained from posterior leg bones of WT mice, following differenciation in HBSS completed with supernatant from L-cells for 5 days. BMDM were collected, allowed to adhere on 6-well dishes and further treated with 5 M μ JWH-133 for 7h. The purity of BMDM was > 95 .
%
Results are the mean of triplicate determinations on 5 wells/condition.
Gelatin zymography
Proteins (50 g) from liver homogenates were obtained as described ( ) and separated on a 10 polyacrylamide gel containing 1 μ
23
% mg/ml of bovine skin gelatin (Sigma). After washing for 2 h in 2.5 Triton X-100, gels were incubated for 18 h at 37 C in 50 mM Tris pH
%°7
.8 containing 5 mM CaCl , stained with Coomassie blue, destained in methanol/acetic acid/water (5/2/13) and fixed in 2 methanol/glycerol/water (2/1/17).
Statistics
Values represent means SEM. Results were analyzed by either Mann and Whitney test, one way or two way ANOVA followed by ± multiple comparison test, as appropriate. p<0.05 was taken as the minimum level of significance.
RESULTS
Induction of CB2 receptors following acute CCl4-induced liver damage
Administration of CCl was associated with a 10-fold induction of CB2 mRNA expression at 24 h that was maintained after 48 h ( These data indicate that CCl induced liver injury is associated with an early induction of CB2 receptors in non-parenchymal cells, 4- including hepatic myofibroblasts and macrophages at 24 h, although polymorphonuclear leukocytes may also contribute to CB2 induction after 48 h.
CB2 receptors reduce acute liver injury
Acute exposure to CCl induces apoptosis of hepatocytes following cytochrome P450 2E1 (CYP-2E1)-dependent generation of 4 hepatotoxic metabolites. We found that CYP-2E1 mRNA expression was similar in CCl -treated CB2
and WT mice, ruling out an 
CB2 receptors accelerate liver regeneration
We investigated the impact of CB2 receptors on the regenerative response arising from CCl -induced injury. Cyclin D1 expression 
CB2 inactivation impairs liver regeneration via an IL-6 dependent inhibition of MMP-2
IL-6 plays a major role in hepatocyte survival and regeneration ( , , ). Given the impairment of IL-6 induction in the liver of 24 25 30 CCl -treated CB2 mice, we explored whether defective liver regeneration would be restored by IL-6 administration. IL-6 did not affect 5 15 animals to 75 of its level in CCl -treated WT animals ( ). These findings suggest that IL-6 deficiency is a key event in the − % 
DISCUSSION
The present study shows that activation of CB2 receptors alleviates CCl -induced hepatitis and accelerates liver regeneration, 4 therefore identifying CB2 agonists as potential beneficial hepatoprotective agents.
We show that hepatic CB2 receptor expression is increased in the non parenchymal cell fraction during acute hepatitis triggered by
CCl . Moreover, our data suggest that early up-regulation of CB2 receptors may arise from macrophages and activated myofibroblasts, 4 while other recruited inflammatory cells (i.e polymorphonuclear leucocytes) most probably also contribute to CB2 receptor induction at later time points. Interestingly, a recent study has reported increased production of the endogenous CB2 ligand 2-arachidonoylglycerol in the liver following a single injection of CCl ( ). Altogether, these data indicate that acute liver injury is associated with an enhancement 4 33 of the endogenous CB2 tone.
We show that in the CCl model, administration of the CB2 agonist JWH-133 reduces the extent of liver injury, whereas CB2 mice 4 / − − are more susceptible to the toxic insult. These findings corroborate previous studies demonstrating hepatoprotective properties of CB2
receptors in experimental models of acute liver injury elicited by ischemia/reperfusion injury, thioacetamide or concanavalin A ( , , 6 19 34 ). In addition, we identify iNOS as a central mediator in the beneficial effects mediated by CB2 receptors. Indeed, CCl -treated CB2 It is well demonstrated that liver injury triggered by CCl is followed by a regenerative response orchestrated by the activation of 4 multiple coordinated pathways, involving cross-talk between hepatocytes and non parenchymal cells ( ). We demonstrate that CB2 25 receptors display beneficial effects on liver regeneration in this model, as well as in the partial hepatectomy model. We also demonstrate that beneficial effects of CB2 receptors are mediated by a pathway distinct from its protective effects against hepatocyte apoptosis, that 6 15 involve IL-6. Thus, CCl -treated CB2 mice display reduced hepatic expression of IL-6, and administration of IL-6 to these animals In conclusion, our data demonstrate that CB2 receptors reduce liver injury and promote liver regeneration following acute insult, by distinct paracrine mechanisms on hepatocytes originating from hepatic myofibroblasts. These results suggest that CB2 agonists display potent hepatoprotective properties, in addition to their antifibrogenic effects.
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